Summit Therapeutics Inc.
Summit Therapeutics Inc. (SMMT) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 66 transactions totaling $332.8M, demonstrating a bullish sentiment with $332.1M in net insider flow. The most recent transaction on Jan 8, 2026 involved a transaction of 30,000 shares valued at $0.
SMMT Insider Activity Summary
Who Is Buying SMMT Stock?
No significant insider buying has been recorded for SMMT in the recent period.
Who Is Selling SMMT Stock?
No significant insider selling has been recorded for SMMT in the recent period.
Is Summit Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SMMT is bullish with an Insider Alignment Score of 100/100 and a net flow of $332.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SMMT Frequently Asked Questions
Understanding SMMT Insider Activity
Insider trading at Summit Therapeutics Inc. (SMMT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading SMMT stock, having executed 66 transactions in the past 90 days. The most active insider is Robert W. Duggan (Executive), who has made 13 transactions totaling $547.6M.
Related Tools
Track Summit Therapeutics Inc. Insider Activity
Get notified when executives and directors at SMMT file new Form 4 transactions